oxLDL binding, inhibit, LOX-1, Inhibitor, BI 0115, BI0115, BI-0115, atherosclerosis
BI-0115 is a selective LOX-1 inhibitor that prevents oxLDL uptake by inducing tetramerization of the receptors ligand-binding domain, thereby blocking its function. This small molecule is a valuable research tool for studying atherosclerosis, endothelial dysfunction, and inflammation in both cellular and animal models.
Molekulargewicht:
287.74
Reinheit:
99.69% (May vary between batches)
CAS Nummer:
[4929-23-1]
Formel:
C15H14ClN3O
Target-Kategorie:
Lipoxygenase
Anwendungsbeschreibung:
Solubility: DMSO:2.88 mg/mL (10.01 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten